SSSS Share Price | SuRo Capital Corp. Stock Analysis & Recommendation

Q: What does SuRo Capital Corp. do?

Overview:SuRo Capital Corp. is an investment fund that focuses on investing in venture-backed private companies within the Capital Markets industry and operates in the micro-cap market segment.Financial Snapshot:Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025) Market-cap: USD 173.11 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -999,999.00 Return on Equity: -10.76% Price to Book: 1.10Contact Details:Address: ONE SANSOME STREET, SUITE 730, SAN FRANCISCO CA: 94104 Tel: 1 650 2354769 Website: https://surocap.com/

Q: Is SuRo Capital Corp. overvalued or undervalued?

As of 19 August 2025, the valuation grade for SuRo Capital Corp. has moved from fair to attractive, indicating a more favorable assessment of its worth. The company appears to be undervalued, especially considering its Price to Book Value of 1.11 and an EV to Capital Employed ratio of 1.12, which suggest that the market may not fully recognize its asset value. Additionally, the peer comparison highlights that SuRo Capital Corp. has a lower P/E ratio of 3.70 compared to BlackRock Capital Investment Corp. at 10.18 and Medallion Financial Corp. at 6.39, reinforcing the notion of undervaluation.In terms of performance, SuRo Capital Corp. has significantly outperformed the S&P 500 over various periods, with a year-to-date return of 56.63% compared to the S&P 500's 12.22% and a one-year return of 137.98% versus 17.14%. This strong performance further supports the argument that the stock is undervalued relative to its recent returns and market position.

Q: Is SuRo Capital Corp. technically bullish or bearish?

As of 12 September 2025, the technical trend for SuRo Capital Corp. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, particularly in the weekly and monthly MACD readings, which are both bullish. The daily moving averages also confirm a bullish trend. However, the weekly RSI is bearish, indicating some short-term weakness. The Bollinger Bands suggest a mildly bullish trend on the weekly and bullish on the monthly. In terms of performance, SuRo Capital has outperformed the S&P 500 across multiple periods, with a year-to-date return of 56.63% compared to the S&P 500's 12.22%, and a one-year return of 137.98% versus 17.14%. Overall, the technical indicators suggest a bullish outlook, albeit with some caution due to the bearish weekly RSI.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

110.19 k

Shareholding (Dec 2025)

FII

1.75%

Held by 14 FIIs

DII

90.73%

Held by 8 DIIs

Promoter

0.00%

How big is SuRo Capital Corp.?

22-Jun-2025

As of Jun 18, SuRo Capital Corp. has a market capitalization of 173.11 million, with net sales of -1.16 million and a net profit of -16.87 million over the latest four quarters. The balance sheet shows shareholder's funds of 157.57 million and total assets of 231.60 million.

View full answer

What does SuRo Capital Corp. do?

22-Jun-2025

SuRo Capital Corp. is an investment fund that invests in venture-backed private companies in the Capital Markets industry, focusing on the micro-cap market segment. As of March 2025, it has a market cap of $173.11 million and reported a net loss of $1 million.

View full answer

Who are in the management team of SuRo Capital Corp.?

22-Jun-2025

As of March 2022, the management team of SuRo Capital Corp. includes Mr. Mark Klein as President, CEO, and Lead Director, with Ms. Lisa Westley and independent directors Mr. Ronald Lott, Mr. Marc Mazur, and Mr. Leonard Potter on the Board of Directors.

View full answer

Is SuRo Capital Corp. overvalued or undervalued?

20-Sep-2025

As of August 19, 2025, SuRo Capital Corp. is considered undervalued with an attractive valuation grade, reflected in its low P/E ratio of 3.70 compared to peers and strong performance, including a year-to-date return of 56.63% versus the S&P 500's 12.22%.

View full answer

Is SuRo Capital Corp. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, SuRo Capital Corp. shows a bullish trend supported by strong MACD indicators and moving averages, despite a bearish weekly RSI, with year-to-date returns of 56.63% compared to the S&P 500's 12.22%.

View full answer

Compare SuRo Capital Corp. with Similar Stocks

Westwood Holdings Group, Inc.Associated Capital Group, Inc.Silvercrest Asset Management Group, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 15.36% and Operating profit at 31.78%

With a growth in Net Sales of 30.61%, the company declared Very Positive results in Sep 25

With ROE of 29.76%, it has a very attractive valuation with a 1.10 Price to Book Value

High Institutional Holdings at 30.47%

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Capital Markets

Market cap

USD 254 Million (Micro Cap)

P/E

4.00

Industry P/E

Dividend Yield

4.65%

Debt Equity

-999,999.00

Return on Equity

29.76%

Price to Book

1.10

Revenue and Profits:

Net Sales:

7 Million

(Quarterly Results - Dec 2025)

Net Profit:

-20 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

14.05%

6 Months

18.01%

1 Year

83.48%

2 Years

124.95%

3 Years

195.52%

4 Years

18.14%

5 Years

-23.1%

SuRo Capital Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

15.36%

EBIT Growth (5y)

31.78%

EBIT to Interest (avg)

36.22

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

0.27%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

30.47%

ROCE (avg)

29.14%

ROE (avg)

17.10%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.10

EV to EBIT

2.70

EV to EBITDA

2.70

EV to Capital Employed

1.12

EV to Sales

5.27

PEG Ratio

0.02

Dividend Yield

4.65%

ROCE (Latest)

41.69%

ROE (Latest)

29.76%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 6 Schemes (7.52%)

Foreign Institutions

Held by 14 Foreign Institutions (1.75%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 29.82% vs -73.36% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -371.62% vs -88.12% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.40",
          "val2": "5.70",
          "chgp": "29.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.80",
          "val2": "8.70",
          "chgp": "-316.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-20.10",
          "val2": "7.40",
          "chgp": "-371.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,548.80%",
          "val2": "1,537.10%",
          "chgp": "-408.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7,080.00% vs 90.74% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 228.08% vs -847.06% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.90",
          "val2": "-0.50",
          "chgp": "7,080.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "53.70",
          "val2": "-33.20",
          "chgp": "261.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.10",
          "val2": "4.80",
          "chgp": "6.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "48.80",
          "val2": "-38.10",
          "chgp": "228.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1,539.30%",
          "val2": "0.00%",
          "chgp": "153.93%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

7.40

5.70

29.82%

Operating Profit (PBDIT) excl Other Income

-18.80

8.70

-316.09%

Interest

1.30

Exceptional Items

0.00

Consolidate Net Profit

-20.10

7.40

-371.62%

Operating Profit Margin (Excl OI)

-2,548.80%

1,537.10%

-408.59%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 29.82% vs -73.36% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -371.62% vs -88.12% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

34.90

-0.50

7,080.00%

Operating Profit (PBDIT) excl Other Income

53.70

-33.20

261.75%

Interest

5.10

4.80

6.25%

Exceptional Items

0.00

Consolidate Net Profit

48.80

-38.10

228.08%

Operating Profit Margin (Excl OI)

1,539.30%

0.00%

153.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 7,080.00% vs 90.74% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 228.08% vs -847.06% in Dec 2024

All Annual Results

Company CV

About SuRo Capital Corp.

SuRo Capital Corp.

Capital Markets

SuRo Capital Corp. (SuRo Capital), formerly Sutter Rock Capital Corp., is an investment fund that seeks to invest in venture-backed private companies. SuRo Capital seeks to create a portfolio of private companies via a repeatable investment approach, as well as to provide investors with access to such companies through its publicly traded common stock.

Company Coordinates

Company Details

ONE SANSOME STREET, SUITE 730 , SAN FRANCISCO CA : 94104

Tel: 1 650 2354769

https://surocap.com/

Registrar Details